January 11-15, 2027 | San Francisco
2027 Participating Companies
Matisse Pharmaceuticals BV is a bio-pharmaceutical clinical stage company dedicated to develop a product portfolio of safe and innovative therapies targeting inflammation characterized by elevated levels of cell free cytotoxic histones.